Aliskiren as an antiproteinuric add-on therapy in primary membranous nephropathy

被引：0
|
作者：
Ankur Gupta
Ambar Khaira
Bakshish Singh
Dipankar M. Bhowmik
Suresh C. Tiwari
机构：
[1] All India Institute of Medical Sciences,Department of Nephrology
来源：
Clinical and Experimental Nephrology | 2009年 / 13卷
关键词：
Proteinuria; Renin; Aldosterone; Angiotensin Receptor Blocker; Aliskiren;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：402 / 403
页数：1
相关论文
共 50 条
  • [11] Primary membranous nephropathy
    Infantino, Maria
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [12] Primary Membranous Nephropathy
    Couser, William G.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 12 (06): : 983 - 997
  • [13] Antihypertensive Efficacy of the Direct Renin Inhibitor Aliskiren as Add-on Therapy in Patients with Poorly Controlled Hypertension
    Tani, Shigemasa
    Kushiro, Toshio
    Takahashi, Atsuhiko
    Kawamata, Hirofumi
    Ohkubo, Katsuaki
    Nagao, Ken
    Hirayama, Atsushi
    INTERNAL MEDICINE, 2016, 55 (05) : 427 - 435
  • [14] Efficacy and Safety of Telitacicept as an Add-On Therapy for Refractory Immunoglobulin A Nephropathy or Immunoglobulin A Vasculitis Nephropathy in Children
    Liu, Jiaojiao
    Han, Xinli
    Jiang, Xiaoyun
    Gao, Xia
    Li, Guomin
    Fang, Xiaoyan
    Chen, Jing
    Zhai, Yihui
    Liu, Jialu
    Pei, Yuxin
    Zhang, Jiayi
    Zhu, Guoqin
    Shen, Qian
    Xu, Hong
    KIDNEY INTERNATIONAL REPORTS, 2025, 10 (03): : 940 - 943
  • [15] SIMULATION OF LONG-TERM CLINICAL BENEFITS AND COSTS OF ADD-ON THERAPY WITH ALISKIREN IN HYPERTENSIVE PATIENTS WITH DIABETIC NEPHROPATHY: A GERMAN STATUTORY HEALTH INSURANCE PERSPECTIVE
    von der Schulenburg, Graf J. M.
    Weycker, D.
    Kaiser, E.
    Neidhardt, K.
    Brede, Y.
    VALUE IN HEALTH, 2011, 14 (07) : A379 - A379
  • [16] Felbamate as add-on therapy
    Li, LM
    Nashef, L
    Moriarty, J
    Duncan, JS
    Sander, JWAS
    EUROPEAN NEUROLOGY, 1996, 36 (03) : 146 - 148
  • [17] Antiproteinuric Response to Add-on Aliskiren in Proteinuric Patients Treated With Dual Blockade of the Renin-Angiotensin System: A 12-Month Prospective Uncontrolled Study
    De Nicola, Luca
    Zamboli, Pasquale
    Bellizzi, Vincenzo
    Stanzione, Giovanna
    Russo, Domenico
    Nappi, Felice
    Minco, Maristella
    Chiodini, Paolo
    Conte, Giuseppe
    Minutolo, Roberto
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (06) : 961 - 963
  • [18] Triple therapy with saxagliptin and dapagliflozin add-on to metformin: safety of dual add-on versus sequential add-on
    Garcia-Sanchez, R.
    Del Prato, S.
    Matthaei, S.
    Iqbal, N.
    Hansen, L.
    Johnsson, E.
    Chen, H.
    Chin, A. J.
    Mathieu, C.
    DIABETOLOGIA, 2015, 58 : S356 - S356
  • [19] Topiramate (topamax) as add-on therapy for patients with primary generalized epilepsy
    Biton, V
    Reife, R
    Kamin, M
    Bobrosky, K
    NEUROLOGY, 1996, 46 (02) : 2024 - 2024
  • [20] Effects of immunosuppressive therapy on renal prognosis in primary membranous nephropathy
    Li, Wangyang
    Cen, Ji
    Qi, Dongli
    Guan, Mijie
    Chen, Jia
    Qin, Xun
    Wu, Shengchun
    Shang, Meifang
    Wei, Lingqiao
    Lu, Xinxu
    Huang, Huiwei
    Wei, Zhe
    Wan, Qijun
    Cheng, Yuan
    BMC NEPHROLOGY, 2024, 25 (01)
12345